Celldex Therapeutics
Celldex is developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 16.508 |
| 2025-03 | 14.018 |
| 2025-04 | 6.159 |
| 2025-05 | 6.817 |
| Source | Traffic Share |
|---|---|
| search | 43.04% |
| direct | 41.93% |
| social | 7.74% |
| referrals | 6.05% |
| paid referrals | 1.19% |
| 0.06% |
| Region | Percentage |
|---|---|
| United States | 84.03% |
| India | 15.97% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| celldex therapeutics | 218 | 2,180 | $4.66 |
| celldex therapeutics careers | 3 | 30 | $0.00 |
| celldesx pipeline | 0 | 0 | $0.00 |
| soluble scf mast cell celldex | 4 | 40 | $0.00 |
| celldex chronic inducible urticaria | 0 | 0 | $0.00 |